Toxicity and functional outcome were evaluated in 199 MSCC-patients irradiated with 1 x 8 Gy. Motor function improved in 54/199 patients (27%). Patients who regained walking ability were 20/78 (26%). Long-term-survivors (> or =12 months) who needed re-irradiation for in-field-recurrence were 19/65 (29%). Acute toxicity was mild, late toxicity not observed. A randomised trial comparing single-fraction RT to multi-fraction RT is mandatory.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.radonc.2004.12.013 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!